ArticleNPJ precision oncology2025

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial.

Agata Blasiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.